Malignant melanoma, appendageal carcinoma, malignant connective… — definitive surgical excision (item 31372)
Therapeutic procedures · Group T8 — Surgical operations
| Benefit | Amount | Gap to fee |
|---|---|---|
| 85% | $314.10 | $55.40 |
| 75% | $277.15 | $92.35 |
Benefit amounts as published in the schedule, not recalculated.
Fee current from 1 Jul 2026.
(Anaes.) — anaesthesia may be claimed separately in association with this item.
Claiming with other items
Explanatory notes · departmental guidance · 3
TN.8.22 Removal of Skin Lesions - (Items 31356 to 31388)
The excision of warts and seborrheic keratoses attracts benefits on an attendance basis with the exceptions outlined in TN.8.9 of the explanatory notes to this category. Excision of pre-malignant lesions including solar keratoses where clin…
TN.8.23 Removal of Skin Lesion From Face - (Items 31245, 31361 to 31364, 31372, 31373, 31379 and 31380)
For the purposes of these items, the face is defined as that portion of the head anterior to the hairline and above the jawline.
TN.8.125 Removal of Skin Lesions - Necessary Excision Diameter - (Items 31356 to 31388)
The necessary excision diameter (or defect size) refers to the lesion size plus a clinically appropriate margin of healthy tissue required with the intent of complete surgical excision. Measurements should be taken prior to excision. Margin…
More in Group T8 — Surgical operations
| Item number | 31372 |
|---|---|
| Category | 3 — Therapeutic procedures |
| Group | T8 — Surgical operations |
| Subheading | — |
| Item type | S (schedule code) |
| Fee type | N (normal) |
| In schedule since | 1 Nov 2016 |
| Fee current from | 1 Jul 2026 |
| GP scope | In scope |
As at 1 Aug 2026 · Shows what the schedule publishes. Not billing advice. · page built 15 Sep 2026